We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Toast
TOST
$19.7B
| $103K | ﹤0.01% |
2,897
+496
| +21% | +$17.9K |
|
1252
Recursion Pharmaceuticals
RXRX
$1.76B
| $102K | ﹤0.01% |
24,986
+8,466
| +51% | +$41.9K |
|
1253
Aurinia Pharmaceuticals
AUPH
$2.06B
| $102K | ﹤0.01% |
6,407
+1,318
| +26% | +$18.7K |
|
1254
Guidewire Software
GWRE
$14.4B
| $102K | ﹤0.01% |
505
+78
| +18% | +$17.3K |
|
1255
Alcoa
AA
$13.5B
| $99.6K | ﹤0.01% |
+1,874
| New | +$76.7K |
|
1256
Apple Hospitality REIT
APLE
$3.71B
| $98.5K | ﹤0.01% |
8,316
+1,160
| +16% | +$13.6K |
|
1257
SL Green Realty
SLG
$4B
| $97.5K | ﹤0.01% |
2,126
-750
| -26% | -$37K |
|
1258
Casey's General Stores
CASY
$31B
| $97.3K | ﹤0.01% |
176
+4
| +2% | +$2.2K |
|
|
MAZE
1259
Maze Therapeutics
MAZE
$1.53B
| $96.9K | ﹤0.01% |
+2,338
| New | +$80.4K |
|
|
SERV
1260
Serve Robotics
SERV
$419M
| $96.6K | ﹤0.01% |
9,308
+769
| +9% | +$9.23K |
|
1261
Broadstone Net Lease
BNL
$4.31B
| $96K | ﹤0.01% |
5,527
+1,385
| +33% | +$24.9K |
|
1262
Zymeworks
ZYME
$1.77B
| $95.8K | ﹤0.01% |
3,637
+731
| +25% | +$15.9K |
|
1263
Brookfield Asset Management
BAM
$87.1B
| $95.7K | ﹤0.01% |
1,827
-1,403
| -43% | -$75.4K |
|
1264
Olema Pharmaceuticals
OLMA
$913M
| $95.5K | ﹤0.01% |
3,822
+1,169
| +44% | +$20.8K |
|
1265
FTAI Aviation
FTAI
$23.3B
| $95.5K | ﹤0.01% |
485
+227
| +88% | +$38.7K |
|
|
NLOP
1266
Net Lease Office Properties
NLOP
$171M
| $94.9K | ﹤0.01% |
4,589
-1,600
| -26% | -$45.3K |
|
1267
Inter&Co
INTR
$2.23B
| $94.9K | ﹤0.01% |
11,191
-6,425
| -36% | -$56.8K |
|
1268
ImmunityBio
IBRX
$8.2B
| $94.8K | ﹤0.01% |
47,863
+11,319
| +31% | +$25.6K |
|
|
ZBIO
1269
Zenas BioPharma
ZBIO
$1.98B
| $94.7K | ﹤0.01% |
+2,608
| New | +$85.8K |
|
|
KC
1270
Kingsoft Cloud Holdings
KC
$3.52B
| $94.6K | ﹤0.01% |
9,148
+1,170
| +15% | +$14.4K |
|
1271
Twist Bioscience
TWST
$7.85B
| $94.2K | ﹤0.01% |
2,971
+637
| +27% | +$19.9K |
|
1272
iShares Floating Rate Bond ETF
FLOT
$10.5B
| $94.1K | ﹤0.01% |
1,850
+450
| +32% | +$22.9K |
|
1273
Carlisle Companies
CSL
$15.2B
| $93.7K | ﹤0.01% |
293
+6
| +2% | +$1.95K |
|
1274
Nurix Therapeutics
NRIX
$2.76B
| $93.4K | ﹤0.01% |
4,926
+1,970
| +67% | +$28.3K |
|
1275
ADT
ADT
$5.34B
| $92.6K | ﹤0.01% |
11,479
-1,447
| -11% | -$12K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.